Shares of Axcelis Technologies Inc. (NASDAQ:ACLS) have been given an average rating of “Buy” by the six analysts that are presently covering the firm. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $16.50.
A number of research firms have issued reports on ACLS. B. Riley reiterated a “buy” rating on shares of Axcelis Technologies in a research note on Wednesday, September 28th. Zacks Investment Research upgraded Axcelis Technologies from a “hold” rating to a “buy” rating and set a $15.00 price target for the company in a research note on Thursday, October 20th. Benchmark Co. reiterated a “buy” rating and set a $16.00 price target on shares of Axcelis Technologies in a research note on Thursday, November 3rd. Finally, Needham & Company LLC reiterated a “buy” rating and set a $15.00 price target (down previously from $17.00) on shares of Axcelis Technologies in a research note on Thursday, November 3rd.
Axcelis Technologies (NASDAQ:ACLS) opened at 15.45 on Friday. The stock’s 50 day moving average price is $14.31 and its 200-day moving average price is $12.84. Axcelis Technologies has a 52 week low of $7.16 and a 52 week high of $16.55. The company has a market cap of $453.74 million, a price-to-earnings ratio of 61.55 and a beta of 1.50.
Axcelis Technologies (NASDAQ:ACLS) last issued its earnings results on Wednesday, November 2nd. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.03. Axcelis Technologies had a return on equity of 4.06% and a net margin of 2.93%. The business earned $67.50 million during the quarter, compared to analyst estimates of $67.74 million. During the same period in the previous year, the company posted $0.05 EPS. The firm’s revenue was down 17.2% compared to the same quarter last year. On average, equities research analysts forecast that Axcelis Technologies will post $0.34 earnings per share for the current fiscal year.
In other news, Director Barbara J. Lundberg sold 7,000 shares of the business’s stock in a transaction that occurred on Monday, December 12th. The stock was sold at an average price of $13.66, for a total value of $95,620.00. Following the transaction, the director now owns 15,762 shares in the company, valued at approximately $215,308.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 5.13% of the stock is owned by insiders.
A number of institutional investors have recently bought and sold shares of the stock. Alliancebernstein L.P. increased its position in Axcelis Technologies by 10.5% in the second quarter. Alliancebernstein L.P. now owns 38,800 shares of the company’s stock valued at $104,000 after buying an additional 3,700 shares during the last quarter. Guggenheim Capital LLC increased its position in Axcelis Technologies by 0.7% in the second quarter. Guggenheim Capital LLC now owns 47,145 shares of the company’s stock valued at $127,000 after buying an additional 306 shares during the last quarter. Credit Suisse AG purchased a new position in Axcelis Technologies during the third quarter valued at approximately $180,000. Highbridge Capital Management LLC purchased a new position in Axcelis Technologies during the second quarter valued at approximately $230,000. Finally, Symmetry Peak Management LLC purchased a new position in Axcelis Technologies during the third quarter valued at approximately $232,000. Institutional investors and hedge funds own 70.74% of the company’s stock.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The Company operates through the manufacture of capital equipment for the semiconductor manufacturing industry segment. The Company sells its equipment to semiconductor chip manufacturers across the world.